Nuvig, Maze, and Antag close funding rounds In other financing news this week, immunomodulation therapy developer Nuvig Therapeutics ... and Nuvig's preclinical pipeline. NVG-2089 is designed ...

SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare ...

Scholar Rock Holding Corporation ... such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious ...

Read all the stories you want.